American Shared Hospital Services (AMS) Q4 2025 earnings review
Pivot to Direct Care Destroys Margins, Triggers Covenant Breach
AMS's strategic shift from equipment leasing to direct patient care is severely cannibalizing its profitability and draining liquidity. Q4 revenue fell 14.8% YoY to $7.7M as the high-margin legacy leasing business contracted 34%. While direct care volumes are stabilizing the top line, they carry significantly higher operating costs, causing Q4 gross margin to collapse to 12% from 35% a year ago. This structural margin compression, combined with $7.5M in full-year capital expenditures, has depleted cash reserves and resulted in the company breaching financial covenants on its $17.3M credit facility.
🐂 Bull Case
The Direct Patient Care segment now accounts for 63% of total revenue. First full-year contributions from three Rhode Island centers and a new center in Puebla, Mexico, drove a 23.7% YoY segment growth for FY25.
A new seven-year lease extension with Orlando Health for the Proton Beam Radiation Therapy (PBRT) system locks in long-term recurring revenue and stabilizes a segment that has struggled with volume volatility.
🐻 Bear Case
Cash dropped 67% year-over-year to $3.7M. The company failed to meet financial covenants on its $17.3M credit facility and is currently relying on 'constructive discussions' for waivers, presenting an immediate balance sheet risk.
The business model shift is a margin killer. Adjusted EBITDA fell 77% YoY in Q4 to just $868,000. Operating costs are completely decoupling from revenue growth.
⚖️ Verdict: 🔴🔴
Strong Bearish. The existential threat of a debt covenant breach, combined with an 89% drop in Q4 gross profits, overshadows any long-term top-line narrative. The company is trading operational stability for severe financial distress.
Key Themes
Debt Covenant Breach and Liquidity Crunch
The most alarming data point in the Q4 release is the failure to meet financial covenants on the company's credit facility. The current portion of long-term debt sits at $17.3M, while cash balances have been drained from $11.3M to $3.7M due to $7.5M in capital expenditures. Management's reliance on obtaining lender waivers introduces severe operational and equity risk.
Structural Margin Degradation
Gross margin is decelerating rapidly, finishing Q4 at 12% ($906k) compared to 35% ($3.2M) in Q4 2024. This confirms analysts' prior concerns that the strategic shift toward direct patient care brings permanently higher staffing and operational costs compared to the legacy high-margin equipment leasing model.
Legacy Leasing Business in Freefall
The medical equipment leasing segment saw Q4 revenue collapse 33.9% YoY to $2.9M. This was driven by the expiration of three Gamma Knife contracts and lower PBRT volumes. For the full year, Gamma Knife revenue fell 5.5% and PBRT revenue cratered 26.0%.
Direct Patient Care Volume Growth
LINAC treatment volumes proved to be a major growth driver, surging to 28,147 sessions in FY25 from 14,662 in FY24. This segments revenue grew 23.7% for the year to $15.5M, validated by the successful ramp-up of the three Rhode Island centers and the international site in Puebla, Mexico.
Gamma Knife Esprit Upgrades
The company is relying heavily on product innovation through the Gamma Knife Esprit platform to defend its remaining lease footprint. The completion of the Esprit upgrade in Lima, Peru, expanded treatment capabilities. Management explicitly highlighted the upcoming Esprit installation in Guadalajara, Mexico, as a primary driver for anticipated 2026 revenue growth.
Cyclical Healthcare Volume Fluctuations
Management continues to blame 'normal cyclical fluctuations' in the broader healthcare industry for PBRT volume weakness (down to 4,056 procedures in FY25 from 5,139 in FY24). This macroeconomic excuse masks a persistent 18-month downward trajectory in this specific modality.
Other KPIs
Decelerating violently. Down 77% YoY from $3.76 million in Q4 2024, and significantly lower than Q3 2025's $1.94 million. This highlights that while top-line revenue stabilized sequentially, core operating profitability is deteriorating.
High capital intensity remains a defining characteristic of the transition. The aggressive spending on Rhode Island upgrades and international center builds (Peru, Mexico) was the primary driver of the cash depletion that triggered the debt covenant breach.
Key Questions
Covenant Breach Mitigation
With $17.3M in current debt and only $3.7M in cash, what are the specific terms being negotiated with the lender for covenant waivers, and will this restrict future capital expenditures for the Bristol and Johnston projects?
Gross Margin Floor
Gross margin compressed to 12% in Q4. Is this the new structural floor for the business given the 63% mix of Direct Patient Care services, or are there one-time Q4 costs obscuring the run-rate profitability?
PBRT Volume Rebound
PBRT revenue was down 26% for the year, attributed to cyclical fluctuations. Given the new 7-year extension with Orlando Health, what concrete data points suggest these volumes will normalize in 2026?